Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
Price:
0.8
USD
Market Closed
Market Cap:
$8.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
US |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
Shareholder Yield
Current shareholder yield for BCLI is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
BCLI Price
Brainstorm Cell Therapeutics Inc
Brainstorm Cell Therapeutics Inc
Annual Price Range
0.8
52w Low
0.475
52w High
1.31
Price Metrics
| Average Annual Return | -46.73% |
| Standard Deviation of Annual Returns | 37.81% |
| Max Drawdown | -99% |
Shares Statistics
| Market Capitalization | 8.8m USD |
| Shares Outstanding | 11 030 000 |
| Percentage of Shares Shorted | 6.46% |
BCLI Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
BCLI's latest stock split occurred on Oct 1, 2024
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, BCLI traded at 0.2303 per share. Afterward, the share price was about 3.25.
The adjusted shares began trading on Oct 1, 2024. This was stock split number 4 in BCLI's history, following the previous one in Sep 16, 2014.
Pre-Split Price
3.4545
0.2303
Post-Split Price
3.25
Before
After
